IMXI vs. ASTH, WLDN, GDRX, FLYW, TASK, DFIN, NVEE, GB, STGW, and UPBD
Should you be buying International Money Express stock or one of its competitors? The main competitors of International Money Express include Astrana Health (ASTH), Willdan Group (WLDN), GoodRx (GDRX), Flywire (FLYW), TaskUs (TASK), Donnelley Financial Solutions (DFIN), NV5 Global (NVEE), Global Blue Group (GB), Stagwell (STGW), and Upbound Group (UPBD). These companies are all part of the "business services" industry.
International Money Express vs. Its Competitors
Astrana Health (NASDAQ:ASTH) and International Money Express (NASDAQ:IMXI) are both small-cap business services companies, but which is the better business? We will compare the two businesses based on the strength of their profitability, earnings, risk, valuation, institutional ownership, media sentiment, dividends and analyst recommendations.
International Money Express has lower revenue, but higher earnings than Astrana Health. International Money Express is trading at a lower price-to-earnings ratio than Astrana Health, indicating that it is currently the more affordable of the two stocks.
International Money Express has a net margin of 8.01% compared to Astrana Health's net margin of 1.04%. International Money Express' return on equity of 42.08% beat Astrana Health's return on equity.
Astrana Health presently has a consensus price target of $53.29, indicating a potential upside of 74.74%. International Money Express has a consensus price target of $19.60, indicating a potential upside of 34.20%. Given Astrana Health's stronger consensus rating and higher probable upside, equities analysts plainly believe Astrana Health is more favorable than International Money Express.
52.8% of Astrana Health shares are owned by institutional investors. Comparatively, 86.7% of International Money Express shares are owned by institutional investors. 8.5% of Astrana Health shares are owned by company insiders. Comparatively, 5.1% of International Money Express shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.
Astrana Health has a beta of 0.85, indicating that its stock price is 15% less volatile than the S&P 500. Comparatively, International Money Express has a beta of 0.96, indicating that its stock price is 4% less volatile than the S&P 500.
In the previous week, International Money Express had 9 more articles in the media than Astrana Health. MarketBeat recorded 15 mentions for International Money Express and 6 mentions for Astrana Health. International Money Express' average media sentiment score of 1.28 beat Astrana Health's score of 0.93 indicating that International Money Express is being referred to more favorably in the news media.
Summary
International Money Express beats Astrana Health on 9 of the 16 factors compared between the two stocks.
Get International Money Express News Delivered to You Automatically
Sign up to receive the latest news and ratings for IMXI and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding IMXI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
International Money Express Competitors List
Related Companies and Tools
This page (NASDAQ:IMXI) was last updated on 9/3/2025 by MarketBeat.com Staff